Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer"
Clinical trial NCT03209492 · COMPLETED
Trial details
- NCT number
- NCT03209492
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-04-01
- Primary completion
- 2017-12-01
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.